Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +30.88%
#3 Cysic Cysic +23.33%
#4 Fabric Protocol Fabric Protocol +19.88%
#5 Nockchain Nockchain +18.95%
#6 Bedrock Bedrock +18.65%
#7 Victoria VR Victoria VR +17.20%
#8 Velvet Velvet +17.00%
#9 Fake World Assets Fake World Assets +16.33%
#10 Tutorial Tutorial +11.41%
Coin of the day
EXOD EXOD
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Peak Bio, Inc. Peak Bio, Inc.

Peak Bio, Inc.

PKBO
Pozycja w akcjach #37553
Peak Bio, Inc. is a biopharmaceutical firm currently in the clinical... Peak Bio, Inc. is a biopharmaceutical firm currently in the clinical development phase, committed to devising treatments for critical, unmet medical needs in the realms of oncology and inflammatory disorders. The company harnesses its unique, proprietary toxin—known as PH-1 or Thailanstatin—a spliceosome modulator, to create its inaugural range of innovative Antibody-Drug Conjugate (ADC) therapies designed for cancer patients facing significant challenges. Additionally, Peak Bio's leading investigational drug, PHP-303, a small molecule, is on the verge of commencing a Phase II dose clinical trial for the rare condition Alpha1 anti-trypsin deficiency (AATD). The company's operations are situated in Palo Alto, California.
Cena akcji
$0.07
Ostatnia synchronizacja: 2024-11-12
Kapitalizacja rynkowa
$1.62M
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Peak Bio, Inc. (PKBO)

Kategoria

Healthcare
Historia stopy dywidendy dla Peak Bio, Inc. (PKBO)
Stopa dywidendy (TTM) dla Peak Bio, Inc. (symbol akcji: PKBO) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Peak Bio, Inc. (PKBO) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
Firma Stopa dywidendy Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
0.48%
BE